Benoist, Guillemette E <br/><br/>
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide.  [electronic resource] 

 -  Clinical pharmacokinetics  11 2016 
 - 1369-1380 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1926 
<br/><br/><label>Standard No.: </label>10.1007/s40262-016-0403-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abiraterone Acetate--pharmacokinetics<br/>Antineoplastic Agents--pharmacokinetics<br/>Area Under Curve<br/>Benzamides<br/>Cytochrome P-450 Enzyme System--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Enzyme Induction--drug effects<br/>Fasting<br/>Half-Life<br/>Humans<br/>Liver Failure--metabolism<br/>Male<br/>Metabolic Clearance Rate<br/>Nitriles<br/>Phenylthiohydantoin--analogs & derivatives<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Receptors, Androgen--drug effects